[go: up one dir, main page]

WO2002034901A8 - Protein kinase - Google Patents

Protein kinase

Info

Publication number
WO2002034901A8
WO2002034901A8 PCT/GB2001/004719 GB0104719W WO0234901A8 WO 2002034901 A8 WO2002034901 A8 WO 2002034901A8 GB 0104719 W GB0104719 W GB 0104719W WO 0234901 A8 WO0234901 A8 WO 0234901A8
Authority
WO
WIPO (PCT)
Prior art keywords
protein kinase
protein
termed
diagnosis
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/004719
Other languages
French (fr)
Other versions
WO2002034901A2 (en
WO2002034901A3 (en
Inventor
Richard Joseph Fagan
Christopher Benjamin Phelps
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inpharmatica Ltd
Original Assignee
Inpharmatica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharmatica Ltd filed Critical Inpharmatica Ltd
Priority to AU2002210705A priority Critical patent/AU2002210705A1/en
Publication of WO2002034901A2 publication Critical patent/WO2002034901A2/en
Publication of WO2002034901A3 publication Critical patent/WO2002034901A3/en
Publication of WO2002034901A8 publication Critical patent/WO2002034901A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

This invention relates to novel proteins, termed BAA34445.1, herein identified as a protein kinase and to the use of this protein and nucleic cid sequence from the encoding gene in the diagnosis, prevention and treatment of disease.
PCT/GB2001/004719 2000-10-24 2001-10-24 Protein kinase Ceased WO2002034901A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002210705A AU2002210705A1 (en) 2000-10-24 2001-10-24 Protein kinase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0026004.2 2000-10-24
GB0026004A GB0026004D0 (en) 2000-10-24 2000-10-24 Novel protein

Publications (3)

Publication Number Publication Date
WO2002034901A2 WO2002034901A2 (en) 2002-05-02
WO2002034901A3 WO2002034901A3 (en) 2002-07-11
WO2002034901A8 true WO2002034901A8 (en) 2002-08-08

Family

ID=9901869

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/004719 Ceased WO2002034901A2 (en) 2000-10-24 2001-10-24 Protein kinase

Country Status (3)

Country Link
AU (1) AU2002210705A1 (en)
GB (1) GB0026004D0 (en)
WO (1) WO2002034901A2 (en)

Also Published As

Publication number Publication date
GB0026004D0 (en) 2000-12-13
WO2002034901A2 (en) 2002-05-02
AU2002210705A1 (en) 2002-05-06
WO2002034901A3 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
WO2002002606A3 (en) Immunisation against chlamydia pneumoniae
WO2002008285A3 (en) Il-17 molecules and uses thereof
WO2003054012A3 (en) Leptin proteins
WO2001053347A3 (en) Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO2002070563A3 (en) Nuclear hormone receptor ligand binding domain
WO2004053117A3 (en) Serine protease
WO2002034901A3 (en) Protein kinase
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
WO2002046380A3 (en) Protein kinase
WO2001072781A3 (en) Human genes and expression products
WO2002070560A3 (en) Nuclear hormone receptor ligand binding domain
WO2002050116A3 (en) Adhesion molecule protein
WO2004056983A3 (en) Metalloprotease proteins
WO2002029023A8 (en) Nicastrin protein
WO2002062845A3 (en) Adhesion molecules
WO2002044382A8 (en) Cytokine-like proteins
WO2002088341A3 (en) P450 proteins
WO2002062976A3 (en) Serine proteases
HK1043155A1 (en) Gene and protein sequences of phage t4 gene 35
WO2002008393A3 (en) Serine protease from yersinia enterocolitica
WO2003100061A3 (en) Three finger toxin fold proteins
WO2003054178A3 (en) Metalloprotease proteins
WO2001072842A3 (en) Human 7-transmembrane proteins and polynucleotides encoding the same
WO2004003011A3 (en) Nuclear hormone receptor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP